Understanding Side Effects and the Patient Experience
Researchers focus on assessing quality of life and toxicity risks in people with breast cancer.
Progress Against Cancer
Researchers focus on assessing quality of life and toxicity risks in people with breast cancer.
Less radiation explored in multiple studies at San Antonio Breast Cancer Symposium, and National Cancer Institute writes next precision medicine chapter.
Study finds supervised physical activity can help improve quality of life and reduce fatigue among people with metastatic breast cancer.
A breast cancer diagnosis can pose innumerable challenges, and with the average age at diagnosis dropping, the impact of treatment on fertility can present yet another heartache. For a woman who wants to conceive,...
PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one of the largest breast cancer meetings in the world. Nestled between the holiday lights bedecking...
The FDA has approved pirtobrutinib for patients with heavily pretreated chronic lymphocytic leukemia or small lymphocytic lymphoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to pirtobrutinib (Jaypirca) for the treatment...
FDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.” The theory has long been supplanted, but contemporary oncology has brought body fluids back into...
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More